YOUTH POTION’S DEMISE?
Has resveratrol’s reign as sovereign panacea abruptly ended? In early December GlaxoSmithKline PLC, the British pharmaceutical behemoth, announced it had given up on resveratrol research to extend life span because of ineffectiveness and adverse effects on the kidneys of subjects in a recent trial. Resveratrol (called SRT5O1 by Glaxo), the... Read More








